Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Approaches to Understanding the Role of Cannabinoids and Inflammation in Anxiety

NCT03491384 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT03491384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03491384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Approaches to Understanding the Role of Cannabinoids and Inflammation in Anxiety
Lead sponsor
University of Colorado, Boulder
Phase
Observational
Overall status
Completed
Start date
April 1, 2018
Completion date
May 17, 2023
Enrollment
361 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, anxiety chronic, anxiety disorders, anxiety generalized, inflammation, inflammatory response